The MCT-1 oncogene product impairs cell cycle checkpoint control and transforms human mammary epithelial cells

Hsin-Ling Hsu1, Bo Shi, Ronald B Gartenhaus

  • 1Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.

Oncogene
|May 18, 2005
PubMed

Insights

Multiple copies in T-cell malignancy (MCT-1) oncogene drives cell transformation and genomic instability. It deregulates cell cycle checkpoints and DNA damage response, promoting cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Multiple copies in T-cell malignancy (MCT-1) is a putative oncogene identified in T-cell lymphoma.
  • MCT-1 overexpression induces cell transformation, proliferation, and activates PI-3K/AKT survival pathways.
  • MCT-1 protein stabilizes in response to DNA damage, but its role in DNA damage response is unknown.

Purpose of the Study:

  • To investigate the impact of MCT-1 overexpression on DNA damage response and cell cycle regulation.
  • To determine MCT-1's role in malignant transformation and genomic instability.

Main Methods:

  • Overexpression and knockdown (siRNA) of MCT-1 in human cell lines.
  • Analysis of DNA damage markers (gamma-H2AX, NBS1, 53BP1 foci).
  • Cell cycle analysis (flow cytometry) after gamma-irradiation.
  • Transformation assays in immortalized human mammary epithelial cells.

Main Results:

  • MCT-1 overexpression deregulates cell cycle checkpoints, enhancing H2AX and NBS1 phosphorylation.
  • MCT-1 increases DNA damage-induced foci (gamma-H2AX, 53BP1) and S-phase population post-irradiation.
  • MCT-1 knockdown attenuates H2AX phosphorylation and G1/S checkpoint defects.
  • MCT-1 transforms human mammary epithelial cells and promotes genomic instability.

Conclusions:

  • MCT-1 plays a critical role in deregulating the DNA damage response and cell cycle checkpoints.
  • MCT-1 contributes to malignant transformation and genomic instability.
  • Targeting MCT-1 may offer therapeutic strategies for T-cell malignancies and other cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...